{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:51:28Z","timestamp":1790034688219,"version":"4.0.1"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01169","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:23:09Z","timestamp":1527726189000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials"],"prefix":"10.3389","volume":"9","author":[{"given":"Georgina","family":"Fl\u00f3rez-Grau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irati","family":"Zubizarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Cabez\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Villoslada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Benitez-Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1212\/01.wnl.0000462309.76486.c5","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"84","author":"Jacques","year":"2015","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1468-1331.2006.01342.x","article-title":"The epidemiology of multiple sclerosis in Europe","volume":"13","author":"Pugliatti","year":"2006","journal-title":"Eur J Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1005757","DOI":"10.1371\/journal.pcbi.1005757","article-title":"Dynamics and heterogeneity of brain damage in multiple sclerosis","volume":"13","author":"Kotelnikova","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nrneurol.2015.14","article-title":"Multiple sclerosis \u2014 a quiet revolution","volume":"11","author":"Ransohoff","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pathophys.2010.04.004","article-title":"The relevance of animal models in multiple sclerosis research","volume":"18","author":"Denic","year":"2011","journal-title":"Pathophysiolgy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5314541","DOI":"10.1155\/2016\/5314541","article-title":"Th17\u2009cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications","volume":"2016","author":"Dos Passos","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17\u2009cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J Neurol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","article-title":"Infiltration of Th1 and Th17\u2009cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis","volume":"24","author":"Murphy","year":"2010","journal-title":"Brain Behav Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.4049\/jimmunol.0801734","article-title":"Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis","volume":"182","author":"Mondal","year":"2009","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7224\/1537-2073.2012-048","article-title":"The incidence and prevalence of neuromyelitis optica","volume":"15","author":"Marrie","year":"2013","journal-title":"Int J MS Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1352458517735191","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in Catalonia: influence of the new 2015 criteria in incidence and prevalence estimates","volume":"1","author":"Sepulveda","year":"2017","journal-title":"Mult Scler"},{"key":"B17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/practneurol-2015-001139","article-title":"Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis","volume":"15","author":"Scolding","year":"2015","journal-title":"Pract Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s13311-015-0400-8","article-title":"Present and future therapies in neuromyelitis optica spectrum disorders","volume":"13","author":"Kleiter","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/sj.bjc.6600512","article-title":"Increased aquaporin 1 water channel expression in human brain tumours","volume":"87","author":"Saadoun","year":"2002","journal-title":"Br J Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/08830180500371207","article-title":"Targeting the TCR: T-cell receptor and peptide-specific tolerance\u2013based strategies for restoring self-tolerance in CNS autoimmune disease","volume":"24","author":"Kohm","year":"2005","journal-title":"Int Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fimmu.2014.00131","article-title":"Human dendritic cell functional specialization in steady-state and inflammation","volume":"5","author":"Boltjes","year":"2014","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1074-7613(03)00182-1","article-title":"Dendritic cells in immunity and tolerance\u2014do they display opposite functions?","volume":"19","author":"Moser","year":"2003","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2003-12-4392","article-title":"Manipulating dendritic cell biology for the active immunotherapy of cancer","volume":"104","author":"O\u2019Neill","year":"2004","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/CJI.0b013e318165f5d2","article-title":"Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale","volume":"31","author":"Kaka","year":"2008","journal-title":"J Immunother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nri1246","article-title":"Dendritic-cell control of pathogen-driven T-cell polarization","volume":"3","author":"Kapsenberg","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1073\/pnas.231606698","article-title":"Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance","volume":"99","author":"Steinman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"789814","DOI":"10.1155\/2013\/789814","article-title":"Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application","volume":"2013","author":"Cabez\u00f3n","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory Crohn\u2019s disease: a phase I study","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"J Crohn\u2019s Colitis"},{"key":"B32","first-page":"S97","article-title":"Inducing tissue specific tolerance in autoimmune disease with tolerogenic dendritic cells","volume":"33","author":"Suwandi","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","article-title":"Development and function of dendritic cell subsets","volume":"40","author":"Mildner","year":"2014","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imm.12117","article-title":"Human dendritic cell subsets","volume":"140","author":"Collin","year":"2013","journal-title":"Immunology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/21645515.2015.1066050","article-title":"Duality at the gate: skin dendritic cells as mediators of vaccine immunity and tolerance","volume":"12","author":"Nirschl","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jdermsci.2014.08.012","article-title":"Human skin dendritic cells in health and disease","volume":"77","author":"Haniffa","year":"2015","journal-title":"J Dermatol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fimmu.2014.00255","article-title":"Dendritic cell-targeted vaccines","volume":"5","author":"Cohn","year":"2014","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1158\/0008-5472.CAN-15-1695","article-title":"Expansion of a BDCA1+CD14+ myeloid cell population in melanoma patients may attenuate the efficacy of dendritic cell vaccines","volume":"76","author":"Bakdash","year":"2016","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1128\/IAI.01851-14","article-title":"BDCA1-positive dendritic cells (DCs) represent a unique human myeloid DC subset that induces innate and adaptive immune responses to Staphylococcus aureus infection","volume":"82","author":"Jin","year":"2014","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.0105-2896.2009.00886.x","article-title":"Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin","volume":"234","author":"Romani","year":"2010","journal-title":"Immunol Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","article-title":"Characterization of human blood dendritic cell subsets","volume":"100","author":"MacDonald","year":"2002","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cti.2015.39","article-title":"Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel","volume":"5","author":"Ohradanova-Repic","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cmi.2014.52","article-title":"Tolerogenic dendritic cells and their applications in transplantation","volume":"12","author":"Li","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: a promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"972865","DOI":"10.1155\/2013\/972865","article-title":"Dendritic cells: cellular mediators for immunological tolerance","volume":"2013","author":"Chung","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4110\/in.2016.16.1.44","article-title":"Dendritic cell-based immunotherapy for rheumatoid arthritis: from bench to bedside","volume":"16","author":"Ahmed","year":"2016","journal-title":"Immune Netw"},{"key":"B49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.20132","article-title":"Immunotherapy of cancer in 2012","volume":"62","author":"Kirkwood","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3389\/fimmu.2017.01671","article-title":"Dendritic cells transduced with single immunoglobulin IL-1-related receptor exhibit immature properties and prolong islet allograft survival","volume":"8","author":"Xue","year":"2017","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7\u2013CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nri3477","article-title":"The role of dendritic cells in autoimmunity","volume":"13","author":"Ganguly","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"28621","DOI":"10.18632\/oncotarget.5765","article-title":"PDGF upregulates CLEC-2 to induce T regulatory cells","volume":"6","author":"Agrawal","year":"2015","journal-title":"Oncotarget"},{"key":"B54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-540-71029-5_11","article-title":"Handbook of experimental pharmacology \u201cdendritic cells,\u201d the use of dexamethasone in the induction of tolerogenic DCs","author":"van Kooten","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12026-011-8255-5","article-title":"Generation of immunogenic and tolerogenic clinical-grade dendritic cells","volume":"51","author":"Kalantari","year":"2011","journal-title":"Immunol Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-128","article-title":"A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines","volume":"11","author":"Garc\u00eda-Gonz\u00e1lez","year":"2013","journal-title":"J Transl Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e52456","DOI":"10.1371\/journal.pone.0052456","article-title":"Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells","volume":"7","author":"Cabez\u00f3n","year":"2012","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2013.00082","article-title":"Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells","volume":"4","author":"Hubo","year":"2013","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jebm.12050","article-title":"Adoptive infusion of tolerance dendritic cells prolongs survival of small intestine allografts in rats: systematic review and meta-analysis","volume":"6","author":"Sun","year":"2013","journal-title":"J Evid Based Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2567.2010.03396.x","article-title":"Tolerogenic dendritic cells and their potential applications","volume":"132","author":"Hu","year":"2011","journal-title":"Immunology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/eji.201141835","article-title":"Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients","volume":"6","author":"Ra\u00efch-Regu\u00e9","year":"2012","journal-title":"Eur J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cns.12342","article-title":"Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis","volume":"21","author":"Mansilla","year":"2015","journal-title":"CNS Neurosci Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.181.4.2483","article-title":"CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1002\/eji.201546274","article-title":"Selective depletion of CD11c(+) CD11b(+) dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE","volume":"46","author":"Wang","year":"2016","journal-title":"Eur J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1365-2249.2001.01573.x","article-title":"Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats","volume":"125","author":"Xiao","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.4049\/jimmunol.1001322","article-title":"Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity","volume":"186","author":"Papenfuss","year":"2011","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/513295","article-title":"Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis","volume":"2015","author":"Xie","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-9-89","article-title":"Comparative study of clinical grade human tolerogenic dendritic cells","volume":"9","author":"Naranjo-G\u00f3mez","year":"2011","journal-title":"J Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/400_2008_13","article-title":"Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis","volume":"51","author":"Turley","year":"2010","journal-title":"Results Probl Cell Differ"},{"key":"B71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1538\/expanim.57.45","article-title":"Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL\/6 mouse: influence of injection route","volume":"57","author":"Aghdami","year":"2008","journal-title":"Exp Anim"},{"key":"B72","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/intimm\/dxh029","article-title":"IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells","volume":"16","author":"Zhang","year":"2004","journal-title":"Int Immunol"},{"key":"B73","article-title":"Tolerogenic dendritic cells from poorly compensated type 1 diabetes patients have decreased ability to induce stable antigen-specific T cell hyporesponsiveness and generation of suppressive regulatory T cells","author":"Sp\u00edsek","year":"2016","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"B75","doi-asserted-by":"publisher","first-page":"ra87","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5483\/BMBRep.2014.47.2.014","article-title":"The pathophysiological role of dendritic cell subsets in psoriasis","volume":"47","author":"Kim","year":"2014","journal-title":"BMB Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3006168","article-title":"Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis","volume":"5","author":"Lutterotti","year":"2013","journal-title":"Sci Transl Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-0036-1579739","article-title":"Immunology of multiple sclerosis","volume":"36","author":"Sospedra","year":"2016","journal-title":"Semin Neurol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(95)91622-9","article-title":"Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis","volume":"346","author":"Medaer","year":"1995","journal-title":"Lancet (London, England)."},{"key":"B81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12026-011-8204-3","article-title":"T cell recognition of weak ligands: roles of signaling, receptor number, and affinity","volume":"50","author":"Edwards","year":"2011","journal-title":"Immunol Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ana.20875","article-title":"Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis","volume":"60","author":"Ifergan","year":"2006","journal-title":"Ann Neurol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e50478","DOI":"10.1371\/journal.pone.0050478","article-title":"T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial","volume":"7","author":"Karussis","year":"2012","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01169\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:23:12Z","timestamp":1527726192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01169\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":83,"alternative-id":["10.3389\/fimmu.2018.01169"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01169","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"article-number":"1169"}}